• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Bill Sibold

Pharma

Sanofi's Dupixent still 'at the beginning' of its journey: exec

The Regeneron-partnered inflammatory disease drug saw sales jump 46% in the first quarter.
Angus Liu Apr 28, 2022 11:37am

Sanofi inks massive Boston lease to house 2,700 employees

Dec 18, 2018 11:30am

Sanofi, Regeneron sock $1B-plus into new meds, Dupixent included

Jan 8, 2018 11:15am

Sanofi's Dupixent clears payer hurdles as scripts ramp up

Jul 31, 2017 10:48am

NICE backflips on Sanofi's Gaucher med Cerdelga

Jun 1, 2017 9:32am

Sanofi Genzyme chief Meeker bows out, Sibold steps in

Apr 5, 2017 9:45am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy